New Stable Isotope Method to Determine Protein Requirements in Critically Ill Children
Development of New Stable Isotope Method to Determine Protein Requirements in Critically Ill Children
1 other identifier
observational
12
1 country
1
Brief Summary
The need for certain components of food (i.e. protein) for critically ill children is not clear. It is important to have critically ill children fed adequately to prevent that their condition becomes worse or that recovery takes longer. Research methods used in the past to investigate the need for protein (Nitrogen Balance calculations), were not sensitive enough in severely ill children. The purpose of this study is to develop a new research method to determine the need for protein in severely ill children. In order to develop this new method, more information is needed on the way the body of these children uses protein in 24-hours. In the present study during 24-hours 8 children of age less than 18 years who are admitted to either the Pediatric ICU or the Cardiovascular ICU. Subjects will receive a standard nutrition, providing an age specific amount of protein (age ≤ 3: 2.52 protein g/kg BW.d; age 4-6: 1.8 protein g/kg BW.d; age \> 10: 1.44 protein g/kg BW.d) via tube feeding. They will also receive a mixture of stable isotopes of amino to investigate protein behavior in the body (protein kinetics) both by infusion in their blood and together with the nutrition. Blood will be drawn every 60 minutes during the 24-hour period and the behavior of protein and the concentrations in blood of amino acids and urea will be measured. Urine will be collected to measure nitrogen balance. The investigators will compare the results of this nitrogen balance method with the results of the stable isotope method. PIM2, PRISM, SIRS criteria will be used to get information on the severity of illness of the subjects. Also body weight and length as well as body composition of the subjects will be measured at the start and after the 24-hour period. Body composition will be measured by Bioelectrical Impedance Spectroscopy. Endpoints of the study are net whole-body protein synthesis (protein balance), 24-hour pattern of protein balance, 24-hour urea production, 24-hour nitrogen balance, 24-hour contribution of arginine kinetics to whole body protein breakdown, 24-hour muscle protein breakdown, splanchnic amino acid extraction and plasma amino acid concentrations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 12, 2012
CompletedFirst Posted
Study publicly available on registry
January 18, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedOctober 11, 2017
October 1, 2017
4.8 years
January 12, 2012
October 10, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Whole body protein synthesis rate
Whole body protein synthesis rate in the fed state
24 hours
Secondary Outcomes (6)
Whole body protein breakdown rate
24 hours
Whole body protein breakdown rate
24 hours
Whole body Arginine production rate
24 h
Splanchnic amino acid extraction
24 hr
Urea production
24 hr
- +1 more secondary outcomes
Study Arms (1)
Standard clinical care
Standard nutritional therapy and treatment
Eligibility Criteria
Stable critically ill children admitted to the Pediatric Intensive Care Unit or Cardiovascular Intensive Care Unit of ACH
You may qualify if:
- Critically ill children with age less than 18 years at the time of enrollment
- Admitted to the Pediatric ICU or Cardiovascular ICU, with an expected stay of \>72 hours
- One arterial line (or umbilical arterial line) and one multi-lumen central venous line (or two peripheral venous catheters) in place.
- Continuous total parenteral nutrition or continuous enteral feeding (e.g. via nasogastric, nasoduodenal, gastric, jejunal tube) with standard nutrition appropriate for age and weight expected during admission.
- No planned major changes or interventions (such as surgery) in the treatment and care of the patient from enrollment to completion of study period (end of 24-hour stable isotope infusion protocol).
- Hemodynamic stable condition (with or without continuous inotropic medication) defined as ≤1 boluses of volume resuscitation for hypotension in 24 hour.
- No significant loss of plasma/blood from wounds or drains, that may influence the results of the study, no chylothorax.
- Informed consent by parent(s) or LAR.
You may not qualify if:
- Congenital/acquired metabolic or endocrine disorders or hepatic or renal failure or anuria or oliguria.
- Gastrointestinal obstructions or any condition that causes malabsorption.
- Active gastro-intestinal bleeding.
- Fluid restriction (\<100 ml/kg BW.day) making administration of intravenous and enteral stable isotopes impossible.
- Any other condition that according to the Principal Investigator or study physician would interfere with collecting study samples (for example isolation due to MRSA infection).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arkansas Children's Hospital
Little Rock, Arkansas, 72202, United States
Related Publications (1)
de Betue CTI, Garcia Casal XC, van Waardenburg DA, Schexnayder SM, Joosten KFM, Deutz NEP, Engelen MPKJ. 24-Hour protein, arginine and citrulline metabolism in fed critically ill children - A stable isotope tracer study. Clin Nutr. 2017 Jun;36(3):876-887. doi: 10.1016/j.clnu.2016.12.023. Epub 2017 Jan 4.
PMID: 28089618DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marielle P Engelen, PhD
University of Arkansas
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
January 12, 2012
First Posted
January 18, 2012
Study Start
February 1, 2008
Primary Completion
December 1, 2012
Study Completion
January 1, 2013
Last Updated
October 11, 2017
Record last verified: 2017-10